Hostname: page-component-cd9895bd7-mkpzs Total loading time: 0 Render date: 2024-12-25T19:43:18.007Z Has data issue: false hasContentIssue false
  • English
  • Français

EARLY AWARENESS AND ALERT SYSTEMS FOR MEDICAL TECHNOLOGIES IN ISRAEL

Published online by Cambridge University Press:  14 September 2012

Orna Tal  and
Nina Hakak
Orna Tal
Affiliation:
The Israeli Center for Technology Assessment in Health Care (ICTAHC), The Gertner Institute for Epidemiology and Health Policy Research, Tel Hashomer; Division of Medical Technology Policy (DMTP), Ministry of Health email: OrnaT@gertner.health.gov.il
Nina Hakak
Affiliation:
The Israeli Center for Technology Assessment in Health Care (ICTAHC)
Get access Rights & Permissions [Opens in a new window]

Abstract

Background: Throughout the world, decision makers face the need to plan on the basis of uncertainty. Prospective updates on future trends of medical technology usage are tools to improve national health status. In Israel, this challenge is met by several steps taken to promote insight into the realm of emerging technologies. Israel's unique horizon strategy refers to three time spans: the immediate to short-term (for the coming year) updating the National List of Health Services (NLHS) and quarterly scanning; the medium-term (3 years to a decade) revitalizing hospital devices and infrastructure; and long-term planning (over a decade), such as the “Health Israel 2020 Project”.

Methods: A description of the Israeli setup of different time spans and tiers.

Results: The matrix of players, loci, interests, population groups, and incentives creates a complex situation and the Ministry of Health has to regulate the different suppliers and tiers of insurance (obligatory, supplementary, and private), balancing need, equity, and cost containment in preparing for future health care. However, preparedness is not a sterile laboratory and is pervaded by numerous dilemmas and the search for adequate evidence for new less mature technologies is an on-going challenge.

Conclusion: Bridging the forecasting chasm for the future requires analyzing needs, reinforcing evidence and seeing “around the corner” when synergizing between all the “actors” in the national arena. Expert consultation and international cooperation with similar horizon organizations can assist in paving the way for more successful planning efforts for future medical technology implementation.

Keywords

Horizon scanningMedical technologiesDilemmas in health policyHealth policy
Type
THEME: EARLY AWARENESS AND ALERT (EAA) METHODS AND SYSTEMS
Information
International Journal of Technology Assessment in Health Care , Volume 28 , Issue 3 , July 2012 , pp. 333 - 338
Copyright
Copyright © Cambridge University Press 2012

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1.Douw, K, Vondeling, H. Selection of new health technologies for assessment aimed at informing decision making: A survey among horizon scanning systems. Int J Technol Assess Health Care. 2006;22:177–183.CrossRefGoogle ScholarPubMed
2.Golan, O, Hansen, P, Kaplan, G, Tal, O. Health technology prioritization: Which criteria for prioritizing new technologies and what are their relative weights? Health Policy. 2011;102:126–135.CrossRefGoogle ScholarPubMed
3.Greenberg, D, Siebzehner, MI, Pliskin, JS. The process of updating the National List of Health Services in Israel: Is it legitimate? Is it fair? Int J Technol Assess Health Care. 2009;25:255–261. doi:10.1017/S026646230999016XCrossRefGoogle ScholarPubMed
4.Guttman, N, Shalev, C, Kaplan, G, et al.What should be given a priority - costly medications for relatively few people or inexpensive ones for many? The Health Parliament Public Consultation Initiative in Israel. Health Expect. 2008;11:177–188.CrossRefGoogle ScholarPubMed
5.Ham, C, Locock, L. International approaches to priority setting in health care. Handbook Series 25. Birmingham, UK: Health Services Management Center, University of Birmingham; 1998.Google Scholar
6.Ibargoyen-Roteta, N, Gutierrez-Ibarluzea, I, Benguria-Arrate, G, Galnares-Cordero, L, Asua, J. Differences in the identification process for new and emerging health technologies: Analysis of the EuroScan database. Int J Technol Assess Health Care. 2009;25:367–373.CrossRefGoogle ScholarPubMed
7.Murphy, K, Packer, C, Stevens, A, Simpson, S. Effective early warning systems for new and emerging health technologies: Developing an evaluation framework and an assessment of current systems. Int J Technol Assess Health Care. 2007;23:324–330.CrossRefGoogle Scholar
8.Nachtnebel, A, Geiger-Gritsch, S, Hintringer, K, Wild, C. Scanning the horizon—Development and implementation of an early awareness system for anticancer drugs in Austria. Health Policy. 2012;104:1–11.CrossRefGoogle ScholarPubMed
9.National Health Insurance Law, State of Israel, 1994.Google Scholar
10.Packer, C. Horizon scanning in England and the EuroScan collaboration. March 2009. http://finohta.stakes.fi/NR/rdonlyres/F3556F0C-FA37–4417-989D-A6A15F90DD07/0/PackerClaire_HelsinkiMUMMworkshopMarch2009.pdf (accessed March 28, 2012).Google Scholar
11.Packer, C, Simpson, S, Stevens, A, on behalf of EuroScan: The European Information Network on New and Changing Health Technologies. International diffusion of new health technologies: A ten-country analysis of six health technologies. Int J Technol Assess Health Care. 2006;22:419–428.CrossRefGoogle Scholar
12.Robert, G, Stevens, A, Gabbay, J. ‘Early warning systems’ for identifying new healthcare technologies. Health Technol Assess. 1999;3:1–108.CrossRefGoogle ScholarPubMed
13.Shani, S, Klang, SH, Haran, B, Shemer, J. Updating the national list of reimbursed drugs in an era of limited resources. Pharm World Sci. 1999;21:A13.Google Scholar
14.Shani, S, Siebzehner, MI, Luxenburg, O, Shemer, J. Setting priorities for the adoption of health technologies on a national level – the Israeli experience. Health Policy. 2000;54:169–185.CrossRefGoogle ScholarPubMed
15.Shemer, J, Shani, M, Tamir, O, Siebzehner, MI. Health technology assessment management in Israel - HTA in action. Int J Technol Assess Health Care. 2009;25 (Suppl 1):134–139.CrossRefGoogle ScholarPubMed
16.Simpson, S, Hiller, J, Gutierrez-Ibarluzea, Iet al., A toolkit for the identification and assessment of new and emerging health technologies. 2009. EuroScan. Birmingham. http://euroscan.org.uk/news/sed-rhoncus/ (accessed December 21, 2011).Google Scholar
17.Tal, O, Marom, E, Applbaum, Y, Rasooly, I. Israel's healthcare system: Looking forward to the year 2020 - Preparing a healthcare model. Logist Health Care. 2007;4:5–10.Google Scholar
18.Tal, O, Sheffer, N, Vaknin, S. Parameters for allocation of Expensive Medical Devices (EMD) as a national regulatory mechanism. Harefuah. 2008;147:359–362Google ScholarPubMed
19.Tal, O. Forecasting medical technologies - a global overview. Harefuah. 2011;150:185–189.Google ScholarPubMed
20.Tamary, H, Bar-Yam, R, Shalmon, L, et al.Fanconi anaemia group A (FANCA) mutations in Israeli non-Ashkenazi Jewish patients. Br J Haematol. 2000;111:338–343. Erratum in: Br J Haematol. 2001;112:829.Google Scholar
21.Taub Center. http://taubcenter.org.il/index.php/category/data_sets/lang/he/(13/7/11 (accessed December 28, 2011).Google Scholar
Supplementary material: File

Tal supplementary material

Tal supplementary material

Download Tal supplementary material(File)
File 37.9 KB